{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:06:08Z","timestamp":1791533168160,"version":"4.3.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Endocrine hypertension (EHT) due to pheochromocytoma\/paraganglioma (PPGL), Cushing\u2019s syndrome (CS), or primary aldosteronism (PA) is linked to a variety of metabolic alterations and comorbidities. Accordingly, patients with EHT and primary hypertension (PHT) are characterized by distinct metabolic profiles. However, it remains unclear whether the metabolomic differences relate solely to the disease-defining hormonal parameters. Therefore, our objective was to study the association of disease defining hormonal excess and concomitant adrenal steroids with metabolomic alterations in patients with EHT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective European multicenter study of 263 patients (mean age 49 years, 50% females; 58 PHT, 69 PPGL, 37 CS, 99 PA) in whom targeted metabolomic and adrenal steroid profiling was available. The association of 13 adrenal steroids with differences in 79 metabolites between PPGL, CS, PA and PHT was examined after correction for age, sex, BMI, and presence of diabetes mellitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After adjustment for BMI and diabetes mellitus significant association between adrenal steroids and metabolites \u2013 18 in PPGL, 15 in CS, and 23 in PA \u2013 were revealed. In PPGL, the majority of metabolite associations were linked to catecholamine excess, whereas in PA, only one metabolite was associated with aldosterone. In contrast, cortisone (16 metabolites), cortisol (6 metabolites), and DHEA (8 metabolites) had the highest number of associated metabolites in PA. In CS, 18-hydroxycortisol significantly influenced 5 metabolites, cortisol affected 4, and cortisone, 11-deoxycortisol, and DHEA each were linked to 3 metabolites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussions<\/jats:title><jats:p>Our study indicates cortisol, cortisone, and catecholamine excess are significantly associated with metabolomic variances in EHT versus PHT patients. Notably, catecholamine excess is key to PPGL\u2019s metabolomic changes, whereas in PA, other non-defining adrenal steroids mainly account for metabolomic differences. In CS, cortisol, alongside other non-defining adrenal hormones, contributes to these differences, suggesting that metabolic disorders and cardiovascular morbidity in these conditions could also be affected by various adrenal steroids.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1370525","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T05:00:21Z","timestamp":1711429221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension"],"prefix":"10.3389","volume":"15","author":[{"given":"Robin","family":"Knuchel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Erlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper K.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Pecori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Langton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Peitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Prejbisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Januszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Remde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2007.01.002","article-title":"Systemic hypertension","volume":"32","author":"Elliott","year":"2007","journal-title":"Curr Problems Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13113","article-title":"Long-term morbidity and mortality in patients with Cushing\u2019s syndrome","volume":"34","author":"Braun","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabet.2019.02.003","article-title":"Links between aldosterone excess and metabolic complications: A comprehensive review","volume":"46","author":"Bothou","year":"2020","journal-title":"Diabetes Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/a-0649-0960","article-title":"Metabolic alterations in patients with pheochromocytoma","volume":"127","author":"Erlic","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/jcm8122194","article-title":"Effects of primary aldosteronism and different therapeutic modalities on glucose metabolism","volume":"8","author":"Kwak","year":"2019","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa954","article-title":"Targeted metabolomics as a tool in discriminating endocrine from primary hypertension","volume":"106","author":"Erlic","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0589","article-title":"Metabolic impact of pheochromocytoma\/paraganglioma: targeted metabolomics in patients before and after tumor removal","volume":"181","author":"Erlic","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201800049","article-title":"Urinary metabolic signature of primary aldosteronism: gender and subtype-specific alterations","volume":"13","author":"Lana","year":"2019","journal-title":"Proteomics Clin Appl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0109","article-title":"Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing\u2019s syndrome","volume":"177","author":"Di Dalmazi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.972","article-title":"The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease","volume":"68","author":"Ussher","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa423","article-title":"Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension","volume":"105","author":"Constantinescu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsbmb.2014.10.006","article-title":"An LC-MS\/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism","volume":"145","author":"Peitzsch","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.239962","article-title":"Interference from 3-O-methyldopa with ultra-high performance LC-MS\/MS measurements of plasma metanephrines: chromatographic separation remains important","volume":"61","author":"Peitzsch","year":"2015","journal-title":"Clin Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/17.6.520","article-title":"Missing value estimation methods for DNA microarrays","volume":"17","author":"Troyanskaya","year":"2001","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.11","article-title":"Using metaboAnalyst 3.0 for comprehensive metabolomics data analysis","volume":"55","author":"Xia","year":"2016","journal-title":"Curr Protoc Bioinf"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/18.suppl_1.S105","article-title":"A variance-stabilizing transformation for gene-expression microarray data","author":"Durbin","year":"2002","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00184.2021","article-title":"Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia susceptibility","volume":"321","author":"Aitken-Buck","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00195","article-title":"The differential effect of excess aldosterone on skeletal muscle mass by sex","volume":"10","author":"Kwak","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.268.3.E501","article-title":"Effect of cortisol on energy expenditure and amino acid metabolism in humans","volume":"268","author":"Brillon","year":"1995","journal-title":"Am J Physiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s00774-018-0959-3","article-title":"Change of skeletal muscle mass in patients with pheochromocytoma","volume":"37","author":"Lee","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2419412","DOI":"10.1155\/2022\/2419412","article-title":"Arginase: biological and therapeutic implications in diabetes mellitus and its complications","volume":"2022","author":"Ren","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.6.1121","article-title":"Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions","volume":"23","author":"F\u00f6rstermann","year":"1994","journal-title":"Hypertension"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81706-6","article-title":"Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis","volume":"334","author":"Hogg","year":"1993","journal-title":"FEBS Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1524-6175.2006.06032.x","article-title":"Nitric oxide in hypertension","volume":"8","author":"Hermann","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-01850-z","article-title":"Protein arginine methyltransferases in cardiovascular and neuronal function","volume":"57","author":"Couto","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41598-018-20549-0","article-title":"Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/biof.3","article-title":"Nitric oxide and vascular insulin resistance","volume":"35","author":"Wu","year":"2009","journal-title":"Biofactors"},{"key":"B43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/1389203717666160627074017","article-title":"L-arginine modulates glucose and lipid metabolism in obesity and diabetes","volume":"18","author":"Hu","year":"2017","journal-title":"Curr Protein Pept Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20061645","article-title":"2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis","volume":"404","author":"Sell","year":"2007","journal-title":"Biochem J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64801","article-title":"2-Aminoadipic acid is a biomarker for diabetes risk","volume":"123","author":"Wang","year":"2013","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13984","article-title":"The relationship between phospholipids and insulin resistance: From clinical to experimental studies","volume":"23","author":"Chang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1098\/rsif.2011.0183","article-title":"System among the corticosteroids: specificity and molecular dynamics","volume":"9","author":"Brookes","year":"2012","journal-title":"J R Soc Interf"},{"key":"B48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078430","article-title":"Plasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146","volume":"8","author":"Then","year":"2013","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.09.009","article-title":"Phosphatidylcholine biosynthesis and lipoprotein metabolism","volume":"1821","author":"Cole","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.671420","article-title":"Local production of lipoprotein-associated phospholipase A and lysophosphatidylcholine in the coronary circulation","volume":"115","author":"Lavi","year":"2007","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"14703203211003781","DOI":"10.1177\/14703203211003781","article-title":"Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis","volume":"22","author":"Jing","year":"2021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"bvac049","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography-tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1370525\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T05:00:25Z","timestamp":1711429225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1370525\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":54,"alternative-id":["10.3389\/fendo.2024.1370525"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1370525","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"article-number":"1370525"}}